Berger JR[au] - Search Results

Year	Number of Results
1969	2
1970	1
1971	2
1974	1
1977	1
1979	1
1981	4
1982	5
1983	4
1984	4
1985	3
1986	4
1987	6
1988	6
1989	7
1990	3
1991	9
1992	12
1993	14
1994	7
1995	7
1996	7
1997	7
1998	10
1999	5
2000	11
2001	7
2002	9
2003	9
2004	7
2005	9
2006	11
2007	10
2008	8
2009	10
2010	10
2011	15
2012	14
2013	9
2014	12
2015	15
2016	13
2017	8
2018	9
2019	11
2020	7
2021	11
2022	6

1

COVID-19 and the nervous system.

Berger JR. Berger JR. J Neurovirol. 2020 Apr;26(2):143-148. doi: 10.1007/s13365-020-00840-5. Epub 2020 May 23. J Neurovirol. 2020. PMID: 32447630 Free PMC article. Review.

2

Vaccines in Multiple Sclerosis.

Williamson EM, Chahin S, Berger JR. Williamson EM, et al. Among authors: berger jr. Curr Neurol Neurosci Rep. 2016 Apr;16(4):36. doi: 10.1007/s11910-016-0637-6. Curr Neurol Neurosci Rep. 2016. PMID: 26922172 Review.

3

Classifying PML risk with disease modifying therapies.

Berger JR. Berger JR. Mult Scler Relat Disord. 2017 Feb;12:59-63. doi: 10.1016/j.msard.2017.01.006. Epub 2017 Jan 6. Mult Scler Relat Disord. 2017. PMID: 28283109 Review.

4

Definition and Consensus Diagnostic Criteria for Neurosarcoidosis: From the Neurosarcoidosis Consortium Consensus Group.

Stern BJ, Royal W 3rd, Gelfand JM, Clifford DB, Tavee J, Pawate S, Berger JR, Aksamit AJ, Krumholz A, Pardo CA, Moller DR, Judson MA, Drent M, Baughman RP. Stern BJ, et al. Among authors: berger jr. JAMA Neurol. 2018 Dec 1;75(12):1546-1553. doi: 10.1001/jamaneurol.2018.2295. JAMA Neurol. 2018. PMID: 30167654

5

PML diagnostic criteria: consensus statement from the AAN Neuroinfectious Disease Section.

Berger JR, Aksamit AJ, Clifford DB, Davis L, Koralnik IJ, Sejvar JJ, Bartt R, Major EO, Nath A. Berger JR, et al. Neurology. 2013 Apr 9;80(15):1430-8. doi: 10.1212/WNL.0b013e31828c2fa1. Neurology. 2013. PMID: 23568998 Free PMC article. Review.

6

Neurosyphilis.

Berger JR, Dean D. Berger JR, et al. Handb Clin Neurol. 2014;121:1461-72. doi: 10.1016/B978-0-7020-4088-7.00098-5. Handb Clin Neurol. 2014. PMID: 24365430 Review.

7

Progressive Multifocal Leukoencephalopathy.

Grebenciucova E, Berger JR. Grebenciucova E, et al. Among authors: berger jr. Neurol Clin. 2018 Nov;36(4):739-750. doi: 10.1016/j.ncl.2018.06.002. Neurol Clin. 2018. PMID: 30366552 Review.

8

Natalizumab.

Berger JR. Berger JR. Drugs Today (Barc). 2006 Oct;42(10):639-55. doi: 10.1358/dot.2006.42.10.1042190. Drugs Today (Barc). 2006. PMID: 17136224 Review.

9

CNS fungal infections: A review.

Nathan CL, Emmert BE, Nelson E, Berger JR. Nathan CL, et al. Among authors: berger jr. J Neurol Sci. 2021 Mar 15;422:117325. doi: 10.1016/j.jns.2021.117325. Epub 2021 Jan 22. J Neurol Sci. 2021. PMID: 33516057 Review. No abstract available.

10

Progressive multifocal leukoencephalopathy.

Berger JR. Berger JR. Handb Clin Neurol. 2014;123:357-76. doi: 10.1016/B978-0-444-53488-0.00017-1. Handb Clin Neurol. 2014. PMID: 25015495 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results